JP2022512158A5 - - Google Patents
Info
- Publication number
- JP2022512158A5 JP2022512158A5 JP2021532805A JP2021532805A JP2022512158A5 JP 2022512158 A5 JP2022512158 A5 JP 2022512158A5 JP 2021532805 A JP2021532805 A JP 2021532805A JP 2021532805 A JP2021532805 A JP 2021532805A JP 2022512158 A5 JP2022512158 A5 JP 2022512158A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administered
- talabostat
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025113459A JP2025156353A (ja) | 2018-12-10 | 2025-07-04 | 免疫調節を使用したがんの治療のための新規アプローチ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862777352P | 2018-12-10 | 2018-12-10 | |
| US62/777,352 | 2018-12-10 | ||
| US201962924429P | 2019-10-22 | 2019-10-22 | |
| US62/924,429 | 2019-10-22 | ||
| PCT/US2019/065465 WO2020123496A1 (en) | 2018-12-10 | 2019-12-10 | Novel approach for treatment of cancer using immunomodulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025113459A Division JP2025156353A (ja) | 2018-12-10 | 2025-07-04 | 免疫調節を使用したがんの治療のための新規アプローチ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512158A JP2022512158A (ja) | 2022-02-02 |
| JP2022512158A5 true JP2022512158A5 (cg-RX-API-DMAC7.html) | 2022-12-02 |
Family
ID=71075816
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532805A Pending JP2022512158A (ja) | 2018-12-10 | 2019-12-10 | 免疫調節を使用したがんの治療のための新規アプローチ |
| JP2025113459A Pending JP2025156353A (ja) | 2018-12-10 | 2025-07-04 | 免疫調節を使用したがんの治療のための新規アプローチ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025113459A Pending JP2025156353A (ja) | 2018-12-10 | 2025-07-04 | 免疫調節を使用したがんの治療のための新規アプローチ |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2991628C (en) | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| WO2021158884A1 (en) * | 2020-02-07 | 2021-08-12 | Bioxcel Therapeutics, Inc. | Treatment regimen for cancer using immunomodulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008033368A2 (en) * | 2006-09-12 | 2008-03-20 | Dara Biosciences, Inc. | Boroproline compound and cytokine combination therapy |
| US9295731B2 (en) * | 2013-04-01 | 2016-03-29 | Mark Quang Nguyen | Cleavable drug conjugates, compositions thereof and methods of use |
| CA2973040A1 (en) * | 2015-01-09 | 2016-07-14 | Mabimmune Diagnostics Ag | Novel anti-fibroblast activation protein (fap) antibodies and uses derived thereof |
| CA2991628C (en) * | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| WO2017058881A1 (en) * | 2015-09-28 | 2017-04-06 | The Trustees Of Columbia University In The City Of New York | Use of pentoxifylline with immune checkpoint-blockade therapies for the treatment of melanoma |
| US11613785B2 (en) * | 2017-01-09 | 2023-03-28 | Onkosxcel Therapeutics, Llc | Predictive and diagnostic methods for prostate cancer |
| CN110914302A (zh) * | 2017-06-01 | 2020-03-24 | 赛托姆克斯治疗学股份有限公司 | 可活化抗pdl1抗体及其使用方法 |
-
2019
- 2019-12-10 CA CA3121270A patent/CA3121270A1/en active Pending
- 2019-12-10 AU AU2019396206A patent/AU2019396206A1/en not_active Abandoned
- 2019-12-10 BR BR112021011205-7A patent/BR112021011205A2/pt not_active IP Right Cessation
- 2019-12-10 CN CN201980087913.2A patent/CN113260361A/zh active Pending
- 2019-12-10 SG SG11202106129RA patent/SG11202106129RA/en unknown
- 2019-12-10 WO PCT/US2019/065465 patent/WO2020123496A1/en not_active Ceased
- 2019-12-10 TW TW108145197A patent/TW202034955A/zh unknown
- 2019-12-10 JP JP2021532805A patent/JP2022512158A/ja active Pending
- 2019-12-10 US US17/312,368 patent/US20220089733A1/en not_active Abandoned
- 2019-12-10 EP EP19894733.5A patent/EP3893869A4/en active Pending
- 2019-12-10 KR KR1020217018080A patent/KR20210102259A/ko not_active Withdrawn
- 2019-12-10 MX MX2021006778A patent/MX2021006778A/es unknown
-
2021
- 2021-06-06 IL IL283742A patent/IL283742A/en unknown
-
2025
- 2025-07-04 JP JP2025113459A patent/JP2025156353A/ja active Pending